IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Galera Therapeutics Inc (GRTX)

CUSIP: 36338D108 | NYSE | 130 institutional holders

Quarters

Q1 2026Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AIkarian Capital, LLC00.0%No shares heldJun 30, 2026No 13F filer matched
13D/AEmerald Bioventures, LLC61,029,97830.2%+20,813,818May 15, 2026No 13F filer matched
13DParvinder Singh Hyare13,521,9216.7%New 5%+ stakeMay 15, 2026No 13F filer matched
13DChang Nancy T8,921,5435.9%New 5%+ stakeDec 30, 2024No 13F filer matched
13G/AIkarian Capital, LLC0
0.0% of class · Jun 30, 2026No shares held
No 13F filer matched
13D/AEmerald Bioventures, LLC61,029,978
30.2% of class · May 15, 2026+20,813,818
No 13F filer matched
13DParvinder Singh Hyare13,521,921
6.7% of class · May 15, 2026New 5%+ stake
No 13F filer matched
13DChang Nancy T8,921,543
5.9% of class · Dec 30, 2024New 5%+ stake
No 13F filer matched

Institutional Holders — Q1 2026

Ascentis Independent Advisors93
0.0% of portfolio›$4
StyleTurnoverLocationFiled
Ascentis Independent Advisors
93$40.0%ETFLowDallas, TX2026-04-28